glucagon vs glp-1 Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review What is GLP-1 & Does
Description
Large clinical trials, including those supporting FDA approval of semaglutide, show that gastrointestinal and appetite-related side effects are almost entirely reversible within weeks to months of stopping treatment
These medications can be expensive, and insurance coverage for weight loss varies widely
Web Page, Alzheimers Disease International, accessed Apr 2024
J Endocrine Soc
By October 2024, the blockbuster drug tirzepatide had transformed Lilly into the most valuable drug company in the world
